Skip to main content
Patent
Medicine
Pharma

Health Care at Reasonable Cost: What’s Next?

This episode is audio from the What’s Next? panel from the Engelberg Center’s Hatch-Waxman at 40 and Beyond Symposium. It was recorded on September 27, 2024.

Donald Beers, Office of Chief Counsel of the Food and Drug Administration (FDA) (retired)

Alfred B. Engelberg

Abbe Gluck, Yale Law School

Arti Rai, Duke University School of Law

Ameet Sarpatwari, Harvard Medical School

Michael Weinberg, Engelberg Center on Innovation Law & Policy, NYU School of Law (moderator)